 | • レポートコード：GIR-107A12143 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、セリアック病のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。セリアック病の種類別市場規模（膨満感、下痢、食欲不振、その他）、用途別市場規模（病院、クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・セリアック病の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Roche、Merck、Johnson & Johnson、BiolineRx、Pfizer、Innovate Biopharmaceuticals、ImmusanT、Novartis、Bristol-Myers Squibb、Immunomedics ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：膨満感、下痢、食欲不振、その他 ・用途別分析2016年-2026年：病院、クリニック ・セリアック病の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・セリアック病のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・セリアック病のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・セリアック病の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・セリアック病の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Celiac Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Celiac Disease size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Celiac Disease market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Celiac Disease market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Distension
Diarrhea
Anorexia
Others
Market segment by Application, can be divided into
Hospital
Clinic
Market segment by players, this report covers
Roche
Merck
Johnson & Johnson
BiolineRx
Pfizer
Innovate Biopharmaceuticals
ImmusanT
Novartis
Bristol-Myers Squibb
Immunomedics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Celiac Disease product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Celiac Disease, with revenue, gross margin and global market share of Celiac Disease from 2019 to 2021.
Chapter 3, the Celiac Disease competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Celiac Disease market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Celiac Disease research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Celiac Disease
1.2 Classification of Celiac Disease by Type
1.2.1 Overview: Global Celiac Disease Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Celiac Disease Revenue Market Share by Type in 2020
1.2.3 Distension
1.2.4 Diarrhea
1.2.5 Anorexia
1.2.6 Others
1.3 Global Celiac Disease Market by Application
1.3.1 Overview: Global Celiac Disease Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Celiac Disease Market Size & Forecast
1.5 Global Celiac Disease Market Size and Forecast by Region
1.5.1 Global Celiac Disease Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Celiac Disease Market Size by Region, (2016-2021)
1.5.3 North America Celiac Disease Market Size and Prospect (2016-2026)
1.5.4 Europe Celiac Disease Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Celiac Disease Market Size and Prospect (2016-2026)
1.5.6 South America Celiac Disease Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Celiac Disease Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Celiac Disease Market Drivers
1.6.2 Celiac Disease Market Restraints
1.6.3 Celiac Disease Trends Analysis
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Celiac Disease Product and Solutions
2.1.4 Roche Celiac Disease Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Roche Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Celiac Disease Product and Solutions
2.2.4 Merck Celiac Disease Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Merck Recent Developments and Future Plans
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Celiac Disease Product and Solutions
2.3.4 Johnson & Johnson Celiac Disease Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Johnson & Johnson Recent Developments and Future Plans
2.4 BiolineRx
2.4.1 BiolineRx Details
2.4.2 BiolineRx Major Business
2.4.3 BiolineRx Celiac Disease Product and Solutions
2.4.4 BiolineRx Celiac Disease Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 BiolineRx Recent Developments and Future Plans
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Celiac Disease Product and Solutions
2.5.4 Pfizer Celiac Disease Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Pfizer Recent Developments and Future Plans
2.6 Innovate Biopharmaceuticals
2.6.1 Innovate Biopharmaceuticals Details
2.6.2 Innovate Biopharmaceuticals Major Business
2.6.3 Innovate Biopharmaceuticals Celiac Disease Product and Solutions
2.6.4 Innovate Biopharmaceuticals Celiac Disease Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Innovate Biopharmaceuticals Recent Developments and Future Plans
2.7 ImmusanT
2.7.1 ImmusanT Details
2.7.2 ImmusanT Major Business
2.7.3 ImmusanT Celiac Disease Product and Solutions
2.7.4 ImmusanT Celiac Disease Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 ImmusanT Recent Developments and Future Plans
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business
2.8.3 Novartis Celiac Disease Product and Solutions
2.8.4 Novartis Celiac Disease Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Novartis Recent Developments and Future Plans
2.9 Bristol-Myers Squibb
2.9.1 Bristol-Myers Squibb Details
2.9.2 Bristol-Myers Squibb Major Business
2.9.3 Bristol-Myers Squibb Celiac Disease Product and Solutions
2.9.4 Bristol-Myers Squibb Celiac Disease Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.10 Immunomedics
2.10.1 Immunomedics Details
2.10.2 Immunomedics Major Business
2.10.3 Immunomedics Celiac Disease Product and Solutions
2.10.4 Immunomedics Celiac Disease Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Immunomedics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Celiac Disease Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Celiac Disease Players Market Share
3.2.2 Top 10 Celiac Disease Players Market Share
3.2.3 Market Competition Trend
3.3 Celiac Disease Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Celiac Disease Revenue and Market Share by Type (2016-2021)
4.2 Global Celiac Disease Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Celiac Disease Revenue Market Share by Application (2016-2021)
5.2 Celiac Disease Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Celiac Disease Revenue by Type (2016-2026)
6.2 North America Celiac Disease Revenue by Application (2016-2026)
6.3 North America Celiac Disease Market Size by Country
6.3.1 North America Celiac Disease Revenue by Country (2016-2026)
6.3.2 United States Celiac Disease Market Size and Forecast (2016-2026)
6.3.3 Canada Celiac Disease Market Size and Forecast (2016-2026)
6.3.4 Mexico Celiac Disease Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Celiac Disease Revenue by Type (2016-2026)
7.2 Europe Celiac Disease Revenue by Application (2016-2026)
7.3 Europe Celiac Disease Market Size by Country
7.3.1 Europe Celiac Disease Revenue by Country (2016-2026)
7.3.2 Germany Celiac Disease Market Size and Forecast (2016-2026)
7.3.3 France Celiac Disease Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Celiac Disease Market Size and Forecast (2016-2026)
7.3.5 Russia Celiac Disease Market Size and Forecast (2016-2026)
7.3.6 Italy Celiac Disease Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Celiac Disease Revenue by Type (2016-2026)
8.2 Asia-Pacific Celiac Disease Revenue by Application (2016-2026)
8.3 Asia-Pacific Celiac Disease Market Size by Region
8.3.1 Asia-Pacific Celiac Disease Revenue by Region (2016-2026)
8.3.2 China Celiac Disease Market Size and Forecast (2016-2026)
8.3.3 Japan Celiac Disease Market Size and Forecast (2016-2026)
8.3.4 South Korea Celiac Disease Market Size and Forecast (2016-2026)
8.3.5 India Celiac Disease Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Celiac Disease Market Size and Forecast (2016-2026)
8.3.7 Australia Celiac Disease Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Celiac Disease Revenue by Type (2016-2026)
9.2 South America Celiac Disease Revenue by Application (2016-2026)
9.3 South America Celiac Disease Market Size by Country
9.3.1 South America Celiac Disease Revenue by Country (2016-2026)
9.3.2 Brazil Celiac Disease Market Size and Forecast (2016-2026)
9.3.3 Argentina Celiac Disease Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Celiac Disease Revenue by Type (2016-2026)
10.2 Middle East & Africa Celiac Disease Revenue by Application (2016-2026)
10.3 Middle East & Africa Celiac Disease Market Size by Country
10.3.1 Middle East & Africa Celiac Disease Revenue by Country (2016-2026)
10.3.2 Turkey Celiac Disease Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Celiac Disease Market Size and Forecast (2016-2026)
10.3.4 UAE Celiac Disease Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Celiac Disease Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Celiac Disease Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Celiac Disease Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Celiac Disease Revenue (USD Million) by Region (2016-2021)
Table 5. Global Celiac Disease Revenue Market Share by Region (2021-2026)
Table 6. Roche Corporate Information, Head Office, and Major Competitors
Table 7. Roche Major Business
Table 8. Roche Celiac Disease Product and Solutions
Table 9. Roche Celiac Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Merck Corporate Information, Head Office, and Major Competitors
Table 11. Merck Major Business
Table 12. Merck Celiac Disease Product and Solutions
Table 13. Merck Celiac Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 15. Johnson & Johnson Major Business
Table 16. Johnson & Johnson Celiac Disease Product and Solutions
Table 17. Johnson & Johnson Celiac Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. BiolineRx Corporate Information, Head Office, and Major Competitors
Table 19. BiolineRx Major Business
Table 20. BiolineRx Celiac Disease Product and Solutions
Table 21. BiolineRx Celiac Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Pfizer Corporate Information, Head Office, and Major Competitors
Table 23. Pfizer Major Business
Table 24. Pfizer Celiac Disease Product and Solutions
Table 25. Pfizer Celiac Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Innovate Biopharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 27. Innovate Biopharmaceuticals Major Business
Table 28. Innovate Biopharmaceuticals Celiac Disease Product and Solutions
Table 29. Innovate Biopharmaceuticals Celiac Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. ImmusanT Corporate Information, Head Office, and Major Competitors
Table 31. ImmusanT Major Business
Table 32. ImmusanT Celiac Disease Product and Solutions
Table 33. ImmusanT Celiac Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Novartis Corporate Information, Head Office, and Major Competitors
Table 35. Novartis Major Business
Table 36. Novartis Celiac Disease Product and Solutions
Table 37. Novartis Celiac Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 39. Bristol-Myers Squibb Major Business
Table 40. Bristol-Myers Squibb Celiac Disease Product and Solutions
Table 41. Bristol-Myers Squibb Celiac Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Immunomedics Corporate Information, Head Office, and Major Competitors
Table 43. Immunomedics Major Business
Table 44. Immunomedics Celiac Disease Product and Solutions
Table 45. Immunomedics Celiac Disease Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Celiac Disease Revenue (USD Million) by Players (2019-2021)
Table 47. Global Celiac Disease Revenue Share by Players (2019-2021)
Table 48. Breakdown of Celiac Disease by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Celiac Disease Players Head Office, Products and Services Provided
Table 50. Celiac Disease Mergers & Acquisitions in the Past Five Years
Table 51. Celiac Disease New Entrants and Expansion Plans
Table 52. Global Celiac Disease Revenue (USD Million) by Type (2016-2021)
Table 53. Global Celiac Disease Revenue Share by Type (2016-2021)
Table 54. Global Celiac Disease Revenue Forecast by Type (2021-2026)
Table 55. Global Celiac Disease Revenue by Application (2016-2021)
Table 56. Global Celiac Disease Revenue Forecast by Application (2021-2026)
Table 57. North America Celiac Disease Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Celiac Disease Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Celiac Disease Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Celiac Disease Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Celiac Disease Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Celiac Disease Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Celiac Disease Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Celiac Disease Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Celiac Disease Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Celiac Disease Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Celiac Disease Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Celiac Disease Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Celiac Disease Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Celiac Disease Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Celiac Disease Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Celiac Disease Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Celiac Disease Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Celiac Disease Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Celiac Disease Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Celiac Disease Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Celiac Disease Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Celiac Disease Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Celiac Disease Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Celiac Disease Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Celiac Disease Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Celiac Disease Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Celiac Disease Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Celiac Disease Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Celiac Disease Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Celiac Disease Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Celiac Disease Picture
Figure 2. Global Celiac Disease Revenue Market Share by Type in 2020
Figure 3. Distension
Figure 4. Diarrhea
Figure 5. Anorexia
Figure 6. Others
Figure 7. Celiac Disease Revenue Market Share by Application in 2020
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Global Celiac Disease Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Celiac Disease Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Celiac Disease Revenue Market Share by Region (2016-2026)
Figure 13. Global Celiac Disease Revenue Market Share by Region in 2020
Figure 14. North America Celiac Disease Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Celiac Disease Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Celiac Disease Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Celiac Disease Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Celiac Disease Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Celiac Disease Market Drivers
Figure 20. Celiac Disease Market Restraints
Figure 21. Celiac Disease Market Trends
Figure 22. Roche Recent Developments and Future Plans
Figure 23. Merck Recent Developments and Future Plans
Figure 24. Johnson & Johnson Recent Developments and Future Plans
Figure 25. BiolineRx Recent Developments and Future Plans
Figure 26. Pfizer Recent Developments and Future Plans
Figure 27. Innovate Biopharmaceuticals Recent Developments and Future Plans
Figure 28. ImmusanT Recent Developments and Future Plans
Figure 29. Novartis Recent Developments and Future Plans
Figure 30. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 31. Immunomedics Recent Developments and Future Plans
Figure 32. Global Celiac Disease Revenue Share by Players in 2020
Figure 33. Celiac Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Celiac Disease Revenue Market Share in 2020
Figure 35. Global Top 10 Players Celiac Disease Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Celiac Disease Revenue Share by Type in 2020
Figure 38. Global Celiac Disease Market Share Forecast by Type (2021-2026)
Figure 39. Global Celiac Disease Revenue Share by Application in 2020
Figure 40. Global Celiac Disease Market Share Forecast by Application (2021-2026)
Figure 41. North America Celiac Disease Sales Market Share by Type (2016-2026)
Figure 42. North America Celiac Disease Sales Market Share by Application (2016-2026)
Figure 43. North America Celiac Disease Revenue Market Share by Country (2016-2026)
Figure 44. United States Celiac Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Celiac Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Celiac Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Celiac Disease Sales Market Share by Type (2016-2026)
Figure 48. Europe Celiac Disease Sales Market Share by Application (2016-2026)
Figure 49. Europe Celiac Disease Revenue Market Share by Country (2016-2026)
Figure 50. Germany Celiac Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Celiac Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Celiac Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Celiac Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Celiac Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Celiac Disease Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Celiac Disease Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Celiac Disease Revenue Market Share by Region (2016-2026)
Figure 58. China Celiac Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Celiac Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Celiac Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Celiac Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Celiac Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Celiac Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Celiac Disease Sales Market Share by Type (2016-2026)
Figure 65. South America Celiac Disease Sales Market Share by Application (2016-2026)
Figure 66. South America Celiac Disease Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Celiac Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Celiac Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Celiac Disease Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Celiac Disease Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Celiac Disease Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Celiac Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Celiac Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Celiac Disease Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界のサイトメガロウイルス病治療市場 2021：企業別、地域別、種類・用途別 The Cytomegalovirus Disease Treatments market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…- 世界の希少疾患診断市場 2021：企業別、地域別、種類・用途別 The Rare Disease Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界のレフサム病治療市場 2021：企業別、地域別、種類・用途別 The Refsum Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界のアルツハイマー病治療市場 2021：企業別、地域別、種類・用途別 The Alzheimer's Disease Treatments market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界のアディソン病治療市場 2021：企業別、地域別、種類・用途別 The Addison's Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…